Directory Category: Drug Discovery

Lyon, France, March 15, 2022óNosopharm, specialized in exploring
unconventional sources of antibiotics to discover new drugs to fight
antimicrobial resistance, today announces that it has signed a
collaboration agreement with the DGIMI laboratory (UMR1333: Diversity,
Genomes and Insects-Microorganisms Interactions). DGIMI falls under
the authority of the French National Research Institute for Agriculture,
Food, and the Environment (INRAE) and the University of Montpellier.
The aim of this collaboration is to produce chemical libraries of new
bioactive molecules which will feed into Nosopharmís anti-infective
screening campaigns against antibiotic resistance. ëFrance Relanceí, the
French government investment plan created following the Covid-19
pandemic, brings financial support to this new collaboration between
Nosopharm, INRAE and University of Montpellier.

RADNOR, Pa., Feb. 11, 2022 /PRNewswire/ — Avantor, Inc. (NYSE:
AVTR), a leading global provider of mission-critical products and
services to customers in the life sciences, advanced technologies and
applied materials industries has started construction on a distribution
center which will help expedite access to essential production materials
for biopharmaceutical manufacturers in Ireland. Expected to open later
this year, the facility will significantly increase distribution
capacity to meet the growing demand for production materials by
Ireland’s biopharma industry.

NIEL, Belgium, Feb. 3, 2022 /PRNewswire/ — eTheRNA immunotherapies
NV (“eTheRNA”) is pleased to announce the start of a strategic
partnership with Merck KGaA, Darmstadt, Germany with the signing of a
Research Agreement. The partnership will investigate the application of
eTheRNA’s proprietary mRNA design expertise and LNP-delivery platforms
to disease areas selected by Merck KGaA, Darmstadt, Germany.